Biomedical Sciences
Global

Biomedical Sciences Experts

Einat Brill Almon

Senior Director
Molecular biology
Protalix
Israel

Biography

Einat Brill Almon, Ph.D. joined Protalix Ltd. in 2004, originally as a Senior Director and later as a Vice President and then Senior Vice President, Product Development, and became our Senior Vice President, Product Development in 2006.  Dr. Almon has many years of experience in the management of life science projects and companies, including biotechnology and agrobiotech, with direct experience in clinical, device and scientific software development, as well as a strong background and work experience in intellectual property.  Prior to joining Protalix Ltd., from 2001 to 2004, she served as Director of R&D and IP of Medgenics Medical (Israel) Ltd. (formerly, Biogenics Ltd.), a company that developed an autologous platform for tissue-based protein drug delivery.  Medgenics Medical, based in Israel, is a wholly-owned subsidiary of Aevi Genomic Medicine, Inc. (formerly, Medgenics Inc.).  Dr. Almon has trained as a biotechnology patent agent at leading IP firms in Israel.  Dr. Almon holds a Ph.D. and an M.Sc. in molecular biology of cancer research from the Weizmann Institute of Science, a B.Sc. from the Hebrew University and has carried out Post-Doctoral research at the Hebrew University in the area of plant molecular biology.

Research Interest

Molecular biology

Global Experts from Israel

Global Experts in Subject